Ukrainian-founded medtech startup DrugCard has raised a new round of investment. Dmytro Gorilik, the startup’s co-founder and CEO, shared the news with AIN.Capital.
DrugCard is a Ukrainian medtech startup. The team is creating a platform for automatic monitoring of medical literature. The product helps pharmaceutical companies reduce costs, optimize routine processes, and ensure compliance with regulatory requirements in pharmacovigilance, — AIN. Capital reports.
Key highlights about the deal:
- New Nordic Ventures became the lead investor.
- The list of investors also included Petro Chernyshov, a business angel who occasionally invests in early-stage Ukrainian startups.
- The amount of the deal is currently undisclosed.
- This is not the first investment for DrugCard: back in 2021, the project raised €255,000 from the pharmaceutical company Farmak and the Spanish venture capital fund Think Bigger Capital.
Read more about investments in Ukrainian startups: Ukrainian Releaf Paper Raises Another EUR 8 million, Half Will be Provided by the European Commission
